PMC:7291971 / 135-1755
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 21-28 | NCBITaxon:10239 | denotes | viruses |
T6 | 56-61 | SP_6;NCBITaxon:9606 | denotes | human |
T7 | 89-97 | SP_7 | denotes | COVID-19 |
T8 | 138-149 | NCBITaxon:11118 | denotes | coronavirus |
T9 | 150-160 | SP_7 | denotes | SARS-CoV-2 |
T10 | 235-239 | UBERON:0001456 | denotes | face |
T11 | 268-275 | NCBITaxon:10239 | denotes | viruses |
T12 | 360-370 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T13 | 495-502 | NCBITaxon:10239 | denotes | viruses |
T14 | 658-668 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T15 | 734-737 | GO:0008541 | denotes | cap |
T16 | 760-765 | NCBITaxon:10239 | denotes | viral |
T17 | 853-863 | CHEBI:22260;CHEBI:22260 | denotes | adenosines |
T18 | 948-957 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T19 | 1008-1020 | NCBITaxon:31032 | denotes | flaviviruses |
T20 | 1024-1032 | SP_10 | denotes | SARS-CoV |
T21 | 1114-1122 | SP_10 | denotes | SARS-CoV |
T22 | 1198-1203 | PR:000000125 | denotes | nsp14 |
T23 | 1204-1213 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T24 | 1302-1311 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T25 | 1361-1370 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T26 | 1435-1438 | GO:0008541 | denotes | cap |
T27 | 1443-1456 | SO:0000409 | denotes | binding sites |
T28 | 1474-1482 | SP_10 | denotes | SARS-CoV |
T29 | 1579-1589 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T30 | 1594-1604 | SP_7 | denotes | SARS-CoV-2 |
T19641 | 21-28 | NCBITaxon:10239 | denotes | viruses |
T61309 | 56-61 | SP_6;NCBITaxon:9606 | denotes | human |
T57953 | 89-97 | SP_7 | denotes | COVID-19 |
T43008 | 138-149 | NCBITaxon:11118 | denotes | coronavirus |
T77356 | 150-160 | SP_7 | denotes | SARS-CoV-2 |
T38673 | 235-239 | UBERON:0001456 | denotes | face |
T98319 | 268-275 | NCBITaxon:10239 | denotes | viruses |
T93340 | 360-370 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T49466 | 495-502 | NCBITaxon:10239 | denotes | viruses |
T50627 | 658-668 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T65425 | 734-737 | GO:0008541 | denotes | cap |
T87174 | 760-765 | NCBITaxon:10239 | denotes | viral |
T40194 | 853-863 | CHEBI:22260;CHEBI:22260 | denotes | adenosines |
T7397 | 948-957 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T53306 | 1008-1020 | NCBITaxon:31032 | denotes | flaviviruses |
T48802 | 1024-1032 | SP_10 | denotes | SARS-CoV |
T86425 | 1114-1122 | SP_10 | denotes | SARS-CoV |
T66103 | 1198-1203 | PR:000000125 | denotes | nsp14 |
T45404 | 1204-1213 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T10534 | 1302-1311 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T99394 | 1361-1370 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T71458 | 1435-1438 | GO:0008541 | denotes | cap |
T73912 | 1443-1456 | SO:0000409 | denotes | binding sites |
T91482 | 1474-1482 | SP_10 | denotes | SARS-CoV |
T91494 | 1579-1589 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T20499 | 1594-1604 | SP_7 | denotes | SARS-CoV-2 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T4 | 235-239 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
T5 | 525-528 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 738-741 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T7 | 821-828 | Body_part | denotes | adenine | http://purl.org/sig/ont/fma/fma82774 |
T8 | 1414-1424 | Body_part | denotes | methionine | http://purl.org/sig/ont/fma/fma82759 |
T9 | 1439-1442 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 235-239 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
10 | 821-842 | Chemical | denotes | adenine dinucleosides | |
11 | 853-863 | Chemical | denotes | adenosines | MESH:D000241 |
12 | 885-893 | Chemical | denotes | nitrogen | MESH:D009584 |
13 | 1313-1323 | Chemical | denotes | sinefungin | MESH:C006235 |
14 | 1414-1424 | Chemical | denotes | methionine | MESH:D008715 |
15 | 1426-1429 | Chemical | denotes | SAM | MESH:D012436 |
16 | 1496-1512 | Chemical | denotes | dinucleoside SAM | |
17 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 89-97 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 150-158 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T4 | 1024-1032 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 1114-1122 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 1474-1482 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 1594-1602 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 21-28 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T2 | 56-61 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T3 | 235-239 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
T4 | 268-275 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T5 | 495-502 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T6 | 970-976 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T7 | 1191-1197 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T8 | 1380-1381 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T6 | 350-359 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T7 | 360-370 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T8 | 610-619 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T9 | 658-668 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T10 | 821-828 | Chemical | denotes | adenine | http://purl.obolibrary.org/obo/CHEBI_16708 |
T11 | 853-863 | Chemical | denotes | adenosines | http://purl.obolibrary.org/obo/CHEBI_22260 |
T12 | 885-893 | Chemical | denotes | nitrogen | http://purl.obolibrary.org/obo/CHEBI_25555 |
T13 | 1204-1213 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T14 | 1302-1311 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T15 | 1313-1323 | Chemical | denotes | sinefungin | http://purl.obolibrary.org/obo/CHEBI_45453 |
T16 | 1361-1370 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T17 | 1403-1424 | Chemical | denotes | S-adenosyl methionine | http://purl.obolibrary.org/obo/CHEBI_15414 |
T18 | 1405-1413 | Chemical | denotes | adenosyl | http://purl.obolibrary.org/obo/CHEBI_33505 |
T19 | 1414-1424 | Chemical | denotes | methionine | http://purl.obolibrary.org/obo/CHEBI_16811|http://purl.obolibrary.org/obo/CHEBI_64558 |
T21 | 1426-1429 | Chemical | denotes | SAM | http://purl.obolibrary.org/obo/CHEBI_15414|http://purl.obolibrary.org/obo/CHEBI_67040 |
T23 | 1509-1512 | Chemical | denotes | SAM | http://purl.obolibrary.org/obo/CHEBI_15414|http://purl.obolibrary.org/obo/CHEBI_67040 |
T25 | 1579-1589 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 715-726 | http://purl.obolibrary.org/obo/GO_0032259 | denotes | methylation |
T3 | 805-814 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-76 | Sentence | denotes | The spreading of new viruses is known to provoke global human health threat. |
T4 | 77-312 | Sentence | denotes | The current COVID-19 pandemic caused by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. |
T5 | 313-451 | Sentence | denotes | The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. |
T6 | 452-633 | Sentence | denotes | Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. |
T7 | 634-778 | Sentence | denotes | We designed bisubstrate inhibitors by mimicking the transition state of the 2′-O-methylation of the cap RNA in order to block viral 2′-O MTases. |
T8 | 779-913 | Sentence | denotes | This work resulted in the synthesis of 16 adenine dinucleosides with both adenosines connected by various nitrogen-containing linkers. |
T9 | 914-1181 | Sentence | denotes | Unexpectedly, all the bisubstrate compounds were barely active against 2′-O MTases of several flaviviruses or SARS-CoV but surprisingly, seven of them showed efficient and specific inhibition against SARS-CoV N7-MTase (nsp14) in the micromolar to submicromolar range. |
T10 | 1182-1324 | Sentence | denotes | The most active nsp14 inhibitor identified is as potent as but particularly more specific than the broad-spectrum MTase inhibitor, sinefungin. |
T11 | 1325-1489 | Sentence | denotes | Molecular docking suggests that the inhibitor binds to a pocket formed by the S-adenosyl methionine (SAM) and cap RNA binding sites, conserved among SARS-CoV nsp14. |
T12 | 1490-1620 | Sentence | denotes | These dinucleoside SAM analogs will serve as starting points for the development of next inhibitors for SARS-CoV-2 nsp14 N7-MTase. |